Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Issuer Symbol
-
CTSO on Nasdaq
There are no Buy or Sell transactions made by Efthymios Deliargyris since 05 Feb 2025
Holdings reported by Efthymios Deliargyris for Cytosorbents Corp
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
473,025 |
$430,452 |
$0.9100 |
08 Aug 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
95,000 |
|
|
08 Aug 2025 |
Direct |
Common Stock |
|
| Series A Right Warrants |
16,233 |
|
|
17 Jan 2025 |
Direct |
Common Stock |
|
| Series B Right Warrants |
16,233 |
|
|
17 Jan 2025 |
Direct |
Common Stock |
|
| Subscription Rights (right to buy) |
0 |
|
|
17 Jan 2025 |
Direct |
Common Stock |
|
Transactions reported by Efthymios Deliargyris for Cytosorbents Corp
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.